PPA
AKRO

Parametric Portfolio Associates’s Akero Therapeutics AKRO Stock Holding History

Parametric Portfolio Associates’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,254
Closed -$207K – 3630
2021
Q3 		$207K Sell
9,254
-790
-8% -$17.9K ﹤0.01% 3427
2021
Q2 		$249K Buy
10,044
+1,272
+15% +$35.7K ﹤0.01% 3329
2021
Q1 		$254K Buy
+8,772
New +$266K ﹤0.01% 3783
2020
Q4 		– Sell
-30,045
Closed -$925K – 3990
2020
Q3 		$925K Buy
+30,045
New +$1.05M ﹤0.01% 2970

Other funds holding AKRO

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return